cyclosporine has been researched along with Delayed Graft Function in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (35.71) | 29.6817 |
| 2010's | 17 (60.71) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Calogero, A; Campanile, S; Carlomagno, N; Dodaro, C; Incollingo, P; Menkulazi, M; Peluso, G; Santangelo, ML; Scotti, A; Tammaro, V | 1 |
| Baumstarck, K; Cassuto, E; Constantin, JM; Fontaine, E; Ichai, C; Leone, M; Orban, JC | 1 |
| Banasik, M; Golebiowski, T; Krajewska, M; Madziarska, K; Madziarski, M; Mazanowska, O; Zmonarski, SC | 1 |
| Campistol, JM; Flechner, SM; Gurkan, A; Hahn, CM; Hartmann, A; Korth-Bradley, JM; Legendre, CM; Li, H; Russ, GR; Schena, FP; Schulman, SL; Tai, SS | 1 |
| Bouamar, R; Budde, K; de Fijter, JW; De Meyer, M; Elens, L; Haufroid, V; Hesselink, DA; Kuypers, DR; Mourad, M; van Gelder, T; van Schaik, RH | 1 |
| Baldan, N; Bonfante, L; Cavallin, F; Donato, P; Furian, L; Marchini, F; Rigotti, P; Silvestre, C; Vallese, L | 1 |
| Ding, C; Ding, X; Feng, X; Hou, J; Li, Y; Pan, X; Tian, P; Tian, X; Xiang, H; Xue, W; Yan, H; Zheng, J | 1 |
| Avila Y Falfan, D; Avila-Pardo, SF; Budar-Fernandez, LF; Martinez-Mier, G; Mateu-Rivera, LJ; Mendez-Lopez, MT; Soto-Miranda, E; Trujillo-Martinez, MF; Uscanga-Montesano, A | 1 |
| Ackaert, O; Bemelman, FJ; Danhof, M; de Fijter, JW; Diack, C; Guchelaar, HJ; Homan van der Heide, JJ; Moes, DJ; Ploeger, BA; Press, RR; Sanders, JS; van der Straaten, T; Wessels, JA | 1 |
| Benigni, A; Deelman, LE; Gomolcak, P; Henning, RH; Kema, IP; Sandovici, M; Seelen, MA; van Goor, H; Vavrincova-Yaghi, D; Vavrinec, P | 1 |
| Banasik, M; Boratyńska, M; Klinger, M; Kościelska-Kasprzak, K; Krajewska, M; Madziarska, K; Mazanowska, O; Myszka, M; Żabińska, M; Zmonarski, SC | 1 |
| Baldelli, S; Cattaneo, D; Donati, D; Gotti, E; Motterlini, N; Perico, N; Remuzzi, G; Rigotti, P; Ruggenenti, P; Salvadori, M; Sandrini, S; Segoloni, G | 1 |
| Asadpour, A; Mehrsai, A; Nikoobakht, MR; Pourmand, G; Rezaeidanesh, M; Salem, S; Saraji, A; Taherimahmoudi, M | 1 |
| Nishii, T; Sakai, T; Sugano, N; Takahara, S; Takao, M; Yoshikawa, H | 1 |
| Badiwala, M; Prodger, J; Ramzy, D; Raoa, V; Ross, H; Sheshgiri, R; Tepperman, E | 1 |
| Bernasconi, C; Ekberg, H; Erken, U; Ketteler, M; Mjörnstedt, L; Navrátil, P; Nöldeke, J; Yussim, A | 1 |
| Azimi, S; Hekmat, S; Hoseini, R; Otukesh, H; Torbati, PM | 1 |
| Bouamar, R; de Fijter, JW; Hesselink, DA; Macphee, IA; van Gelder, T; van Schaik, RH; Weimar, W | 1 |
| Armstrong, VW; Budde, K; de Fijter, H; Kuypers, D; Mamelok, RD; Oellerich, M; Silva, HT; van Gelder, T | 1 |
| Bouamar, R; Elens, L; Haufroid, V; Hesselink, DA; van Gelder, T; van Schaik, RH | 1 |
| Codreanu, I; Cravedi, P; Remuzzi, G; Ruggenenti, P; Satta, A; Sghirlanzoni, M; Turturro, M | 1 |
| Waid, T | 1 |
| Felipe, CR; Franco, M; Garcia, R; Medina-Pestana, J; Moreira, SR; Park, SI; Pinheiro-Machado, P; Silva, LA; Tedesco-Silva, H | 1 |
| Brandenburg, VM; Floege, J; Guetgemann, A; Ketteler, M; Riehl, J | 1 |
| Bestard, O; Cruzado, JM; Gil-Vernet, S; Grinyó, JM; Martínez-Castelao, A; Moreso, F; Rama, I; Riera, L; Serón, D; Torras, J | 1 |
| Eklund, BH; Kyllönen, LE; Pesonen, EJ; Salmela, KT | 1 |
| Chen, YC; Fang, JT; Hsu, HJ; Lai, BC; Tian, YC; Wu, MS; Yang, CW | 1 |
| Abramowicz, D; Broeders, N; Donckier, V; Ghisdal, L; Hoang, AD; Loi, P; Mboti, F; Mikhalski, D; Touly, M; Vereerstraeten, P; Wissing, KM | 1 |
1 review(s) available for cyclosporine and Delayed Graft Function
| Article | Year |
|---|---|
Surgical biology for the clinician: vascular effects of immunosuppression.
Topics: Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Cyclosporine; Delayed Graft Function; Endothelium, Vascular; Everolimus; Graft Rejection; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immune Tolerance; Immunosuppressive Agents; Sirolimus; Tacrolimus; Transplantation Immunology | 2010 |
10 trial(s) available for cyclosporine and Delayed Graft Function
| Article | Year |
|---|---|
Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Cyclosporine; Delayed Graft Function; Double-Blind Method; Drug Administration Schedule; Female; France; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Time Factors; Tissue Donors; Treatment Outcome; Young Adult | 2018 |
A randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipients.
Topics: Adult; Cyclosporine; Delayed Graft Function; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Sirolimus; Transplantation, Homologous | 2013 |
Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients.
Topics: Adult; Alleles; Cyclosporine; Cytochrome P-450 CYP3A; Delayed Graft Function; Dose-Response Relationship, Drug; Follow-Up Studies; Genotype; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; NADPH-Ferrihemoprotein Reductase; Polymorphism, Single Nucleotide; Prospective Studies; Tacrolimus | 2014 |
Outcomes of standard dose EC-MPS with low exposure to CsA in DCD renal transplantation recipients with DGF.
Topics: Administration, Oral; Adult; China; Cyclosporine; Delayed Graft Function; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Tablets, Enteric-Coated; Tissue Donors; Transplant Recipients; Treatment Outcome | 2015 |
Exploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipients.
Topics: Adult; Antibodies; Biomarkers; Biopsy; Cyclosporine; Delayed Graft Function; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Pharmacogenetics; Prevalence; Prospective Studies; Risk Factors; Time Factors | 2016 |
Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Calcineurin Inhibitors; Cyclosporine; Daclizumab; Delayed Graft Function; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infections; Kidney Transplantation; Lipid Metabolism; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Sirolimus; Tacrolimus; Treatment Outcome | 2010 |
Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Creatinine; Cyclosporine; Cytochrome P-450 CYP3A; Delayed Graft Function; Female; Genotype; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Internationality; Kidney Transplantation; Male; Mycophenolic Acid; Polymorphism, Single Nucleotide; Treatment Outcome | 2011 |
How delayed graft function impacts exposure to mycophenolic acid in patients after renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Area Under Curve; Creatinine; Cyclosporine; Delayed Graft Function; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Opportunistic Infections; Tacrolimus; Treatment Failure | 2011 |
Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Topics: Biopsy; Creatinine; Cyclosporine; Delayed Graft Function; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Tacrolimus; Treatment Outcome | 2005 |
Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; Cyclosporine; Delayed Graft Function; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Recombinant Fusion Proteins; Renal Dialysis; Time Factors; Treatment Outcome | 2007 |
17 other study(ies) available for cyclosporine and Delayed Graft Function
| Article | Year |
|---|---|
Relation Between Wound Complication and Lymphocele After Kidney Transplantation: A Monocentric Study.
Topics: Adult; Aged; Cyclosporine; Delayed Graft Function; Diabetes Complications; Female; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphocele; Male; Middle Aged; Obesity; Retrospective Studies; Risk Factors; Sirolimus; Surgical Wound Dehiscence; Tacrolimus | 2020 |
Can the Toll-like receptors 4 expression in peripheral blood mononuclear cells help assess the effectiveness of immunosuppression and the chance of a future good renal transplant function?
Topics: Adult; Biomarkers; Cyclosporine; Delayed Graft Function; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukocytes, Mononuclear; Male; Middle Aged; Mycophenolic Acid; Prognosis; Tacrolimus; Toll-Like Receptor 4; Treatment Outcome | 2019 |
Everolimus associated with low-dose calcineurin inhibitors, an option in kidney transplant recipients of very old donors.
Topics: Aged; Calcineurin Inhibitors; Cyclosporine; Delayed Graft Function; Everolimus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Sirolimus; Steroids; Tacrolimus; Tissue Donors; Transplant Recipients | 2014 |
Induction Immunosuppressive Therapy Use in Deceased Donor Kidney Transplantation: 11-Year Experience in Veracruz, Mexico.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; Calcineurin Inhibitors; Child; Child, Preschool; Creatinine; Cyclosporine; Delayed Graft Function; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Male; Mexico; Middle Aged; Recombinant Fusion Proteins; Retrospective Studies; Tissue Donors; Young Adult | 2016 |
Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction.
Topics: Adenoviridae; Animals; Cyclosporine; Delayed Graft Function; Forkhead Box Protein O3; Genetic Therapy; Genetic Vectors; Graft Survival; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kidney; Kidney Transplantation; Male; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2016 |
Lowering of Messenger Ribonucleic Acid Toll-Like Receptors 2-4,9 in Peripheral Blood Mononuclear Cells in Kidney Allograft Recipients, Relationships With Immunosuppressive Treatment, and Delayed Graft Function Occurrence.
Topics: Adult; Allografts; Calcineurin Inhibitors; Cyclosporine; Delayed Graft Function; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Leukocytes, Mononuclear; Male; Middle Aged; Mycophenolic Acid; RNA, Messenger; Tacrolimus; Toll-Like Receptors | 2016 |
ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Delayed Graft Function; Female; Genotype; Glomerular Filtration Rate; Haplotypes; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prospective Studies | 2009 |
Could prophylactic monoclonal antibody improve kidney graft survival?
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Creatinine; Cyclosporine; Cytomegalovirus Infections; Daclizumab; Delayed Graft Function; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisolone; Treatment Outcome; Urinary Tract Infections; Young Adult | 2009 |
Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients.
Topics: ABO Blood-Group System; Adolescent; Adult; Body Mass Index; Child; Cyclosporine; Delayed Graft Function; Female; Graft Rejection; Hip; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Knee; Male; Middle Aged; Osteonecrosis; Tacrolimus; Treatment Outcome; Young Adult | 2011 |
Early graft dysfunction in a child with renal transplantation.
Topics: Child; Cyclosporine; Delayed Graft Function; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Sirolimus | 2011 |
The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patients.
Topics: Adult; Clinical Trials as Topic; Creatinine; Cyclosporine; Cytochrome P-450 CYP3A; Delayed Graft Function; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Polymorphism, Single Nucleotide | 2012 |
Cyclosporine prolongs delayed graft function in kidney transplantation: are rabbit anti-human thymocyte globulins the answer?
Topics: Adult; Animals; Antilymphocyte Serum; Cyclosporine; Delayed Graft Function; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Rabbits; Retrospective Studies; Time Factors | 2005 |
Impact of initial exposure to calcineurin inhibitors on kidney graft function of patients at high risk to develop delayed graft function.
Topics: Adult; Azathioprine; Biopsy; Calcineurin Inhibitors; Creatinine; Cyclosporine; Delayed Graft Function; Drug Administration Schedule; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Retrospective Studies; Risk Factors; Severity of Illness Index; Tacrolimus; Treatment Outcome | 2006 |
Unclear fever 7 weeks after renal transplantation in a 56-year-old patient.
Topics: Abscess; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biopsy, Fine-Needle; Caspofungin; Contraindications; Cyclosporine; Delayed Graft Function; Drug Interactions; Echinocandins; Fever of Unknown Origin; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lipopeptides; Male; Middle Aged; Mycophenolic Acid; Peptides, Cyclic; Postoperative Complications; Prednisone; Pyrimidines; Radionuclide Imaging; Stenotrophomonas maltophilia; Surgical Wound Infection; Thyroiditis; Triazoles; Ultrasonography; Voriconazole | 2006 |
Immunosuppression for dual kidney transplantation with marginal organs: the old is better yet.
Topics: Calcineurin Inhibitors; Cardiovascular Diseases; Cyclosporine; Delayed Graft Function; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone; Risk; Treatment Outcome | 2007 |
The combination of sirolimus and cyclosporine does not delay initial renal graft function recovery.
Topics: Adult; Cyclosporine; Delayed Graft Function; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Sirolimus | 2008 |
Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
Topics: Adult; Cohort Studies; Cold Ischemia; Cyclosporine; Delayed Graft Function; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Tacrolimus | 2008 |